| Income statement (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 402.07B | 372.81B | 357.78B | 322.47B | 292.11B | 268.71B |
| Cost of revenue | 221.17B | 206.29B | 217.10B | 196.89B | 175.80B | 163.98B |
| Gross profit | 180.90B | 166.52B | 140.68B | 125.58B | 116.31B | 104.72B |
| Operating expenses | 397.41B | 364.29B | 344.03B | 314.51B | 278.80B | 254.79B |
| Operating income | 4.66B | 8.52B | 13.74B | 7.95B | 13.31B | 13.91B |
| EBITDA | 9.27B | 13.11B | 18.11B | 12.18B | 17.80B | 18.35B |
| Interest expense | 3.12B | 2.96B | 2.66B | 2.29B | 2.50B | 2.91B |
| Income before tax | 2.14B | 6.15B | 11.17B | 5.84B | 10.54B | 9.77B |
| Income tax | 408.00M | 1.56B | 2.81B | 1.51B | 2.55B | 2.57B |
| Net income | 1.77B | 4.61B | 8.34B | 4.31B | 8.00B | 7.18B |
| EPS | 1.40 | 3.67 | 6.49 | 3.29 | 6.07 | 5.48 |
| EPS (diluted) | 1.39 | 3.66 | 6.47 | 3.26 | 6.02 | 5.46 |
| Diluted shares | 1.27B | 1.26B | 1.29B | 1.32B | 1.33B | 1.31B |
| Dividends per share | 2.66 | 2.66 | 2.42 | 2.20 | 2.00 | 2.00 |
From CVS Health's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.